These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 12094566)
1. Therapeutic uses of antioxidant liposomes. Stone WL; Mukherjee S; Smith M; Das SK Methods Mol Biol; 2002; 199():145-61. PubMed ID: 12094566 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic uses of antioxidant liposomes. Stone WL; Smith M Mol Biotechnol; 2004 Jul; 27(3):217-30. PubMed ID: 15247495 [TBL] [Abstract][Full Text] [Related]
3. Drug targeting to inflammation: studies on antioxidant surface loaded diclofenac liposomes. Jukanti R; Devaraj G; Devaraj R; Apte S Int J Pharm; 2011 Jul; 414(1-2):179-85. PubMed ID: 21605645 [TBL] [Abstract][Full Text] [Related]
4. Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin. Vanaja K; Wahl MA; Bukarica L; Heinle H Life Sci; 2013 Dec; 93(24):917-23. PubMed ID: 24177602 [TBL] [Abstract][Full Text] [Related]
5. Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain. Sinha J; Das N; Basu MK Biomed Pharmacother; 2001 Jun; 55(5):264-71. PubMed ID: 11428552 [TBL] [Abstract][Full Text] [Related]
6. Investigation into the role of Cu/Zn-SOD delivery system on its antioxidant and antiinflammatory activity in rat model of peritonitis. Porfire AS; Leucuţa SE; Kiss B; Loghin F; Pârvu AE Pharmacol Rep; 2014 Aug; 66(4):670-6. PubMed ID: 24948070 [TBL] [Abstract][Full Text] [Related]
7. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. Shek PN; Suntres ZE; Brooks JI J Drug Target; 1994; 2(5):431-42. PubMed ID: 7704488 [TBL] [Abstract][Full Text] [Related]
8. Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol. Caddeo C; Pucci L; Gabriele M; Carbone C; Fernàndez-Busquets X; Valenti D; Pons R; Vassallo A; Fadda AM; Manconi M Int J Pharm; 2018 Mar; 538(1-2):40-47. PubMed ID: 29294324 [TBL] [Abstract][Full Text] [Related]
9. [Disorders of cardiac contractile function in ischemic shock; the protective effect of antioxidants and liposomes made from egg phospholipids]. Bilenko MV; Morgunov AA; Churakova TD; Bulgakov VG; Komarov PG Biull Eksp Biol Med; 1989 Dec; 108(12):660-3. PubMed ID: 2634433 [TBL] [Abstract][Full Text] [Related]
10. Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Suntres ZE; Shek PN Shock; 1996; 6 Suppl 1():S57-64. PubMed ID: 8828099 [TBL] [Abstract][Full Text] [Related]
11. Smart liposomal drug delivery for treatment of oxidative stress model in human embryonic stem cell-derived retinal pigment epithelial cells. Behroozi F; Abdkhodaie MJ; Abandansari HS; Satarian L; Ashtiani MK; Jaafari MR; Baharvand H Int J Pharm; 2018 Sep; 548(1):62-72. PubMed ID: 29802900 [TBL] [Abstract][Full Text] [Related]
12. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities. Eftekhari A; Dizaj SM; Chodari L; Sunar S; Hasanzadeh A; Ahmadian E; Hasanzadeh M Biomed Pharmacother; 2018 Jul; 103():1018-1027. PubMed ID: 29710659 [TBL] [Abstract][Full Text] [Related]
13. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Jain AK; Mehra NK; Swarnakar NK Curr Pharm Des; 2015; 21(30):4441-55. PubMed ID: 26234792 [TBL] [Abstract][Full Text] [Related]
14. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. Ratnam DV; Ankola DD; Bhardwaj V; Sahana DK; Kumar MN J Control Release; 2006 Jul; 113(3):189-207. PubMed ID: 16790290 [TBL] [Abstract][Full Text] [Related]
15. Recent trends in drug delivery systems: liposomal drug delivery system--preparation and characterisation. Chandran S; Roy A; Mishra B Indian J Exp Biol; 1997 Aug; 35(8):801-9. PubMed ID: 9475051 [TBL] [Abstract][Full Text] [Related]